Global Veterinary Diagnostics Market to Reach USD 23.99 Billion by 2034 as AI, Point-of-Care Testing and Preventive Animal Healthcare Accelerate Growth
The Global Veterinary Diagnostics Market was valued at USD 9.72 Billion in 2025 and is projected to reach USD 23.99 Billion by 2034, expanding at a CAGR of 10.56% during 2026–2034. Growth is being supported by increasing pet ownership, greater expenditure on companion-animal healthcare, heightened awareness of zoonotic diseases, stricter livestock-health monitoring and continued adoption of rapid diagnostic technologies. Growing demand for point-of-care testing, molecular diagnostics, automated laboratory systems and artificial intelligence-enabled diagnostic platforms is also changing how veterinarians identify and manage diseases.
Market Growth Drivers and Emerging Opportunities
Veterinary diagnostics has become an important component of preventive animal healthcare because early and accurate disease detection helps veterinarians improve treatment decisions while supporting livestock productivity and disease-control programs. Rising incidence and surveillance of infectious and zoonotic diseases are encouraging governments, farms, laboratories and veterinary clinics to expand diagnostic capabilities.
Request a Free Sample Report for Comprehensive Market Insights:
https://www.maximizemarketresearch.com/request-sample/34589/
A major opportunity is emerging in rapid point-of-care diagnostics, where testing can be performed directly in veterinary clinics or farm environments instead of requiring samples to be sent to centralized laboratories. Advances in AI-based image interpretation, automated hematology, digital cytology and molecular testing are shortening turnaround times and expanding the range of conditions that can be evaluated during a veterinary visit. The MMR analysis identifies point-of-care tools and AI-enabled diagnostic systems among the important opportunities shaping future market development.
United States Veterinary Diagnostics Market Trends and Investment in 2025
The United States remained a central market for veterinary diagnostic innovation during 2025. IDEXX introduced IDEXX Cancer Dx, a blood-based diagnostic panel designed initially for early detection of canine lymphoma, expanding the role of diagnostics from disease confirmation toward earlier screening. The company also launched the Catalyst Cortisol Test in June 2025, allowing veterinarians to obtain quantitative cortisol measurements at the point of care for dogs being evaluated for Addison’s disease and Cushing’s syndrome.
Investment in laboratory infrastructure also increased. In May 2025, Zoetis opened its largest diagnostics reference laboratory in Louisville, Kentucky, expanding testing capacity and using the location’s logistics infrastructure to improve sample movement and turnaround times across the United States.
Federal disease-surveillance infrastructure further supports diagnostic demand. USDA’s National Animal Health Laboratory Network reported USD 43.16 million in FY2025 allocated funding, including support for veterinary diagnostic infrastructure, high-pathogenic avian influenza testing and emerging dairy-cattle disease events.
Market Segmentation: Leading Segments
By testing type, Immunoassays or Immunodiagnostics dominated the Veterinary Diagnostics Market in 2025. Their leadership is supported by widespread use in detecting infectious diseases, hormones and metabolic conditions. ELISA, lateral-flow testing and automated immunoassay systems offer relatively rapid, sensitive and cost-effective testing options for both laboratories and point-of-care environments.
By end use, the Laboratories segment held approximately 49% of the market in 2025, representing the largest share. Diagnostic laboratories remain essential for disease surveillance, confirmatory testing, research, quality assurance and national programs for monitoring transboundary animal diseases.
Global Veterinary Diagnostics Market to Reach USD 23.99 Billion by 2034 as AI, Point-of-Care Testing and Preventive Animal Healthcare Accelerate Growth
The Global Veterinary Diagnostics Market was valued at USD 9.72 Billion in 2025 and is projected to reach USD 23.99 Billion by 2034, expanding at a CAGR of 10.56% during 2026–2034. Growth is being supported by increasing pet ownership, greater expenditure on companion-animal healthcare, heightened awareness of zoonotic diseases, stricter livestock-health monitoring and continued adoption of rapid diagnostic technologies. Growing demand for point-of-care testing, molecular diagnostics, automated laboratory systems and artificial intelligence-enabled diagnostic platforms is also changing how veterinarians identify and manage diseases.
Market Growth Drivers and Emerging Opportunities
Veterinary diagnostics has become an important component of preventive animal healthcare because early and accurate disease detection helps veterinarians improve treatment decisions while supporting livestock productivity and disease-control programs. Rising incidence and surveillance of infectious and zoonotic diseases are encouraging governments, farms, laboratories and veterinary clinics to expand diagnostic capabilities.
Request a Free Sample Report for Comprehensive Market Insights:https://www.maximizemarketresearch.com/request-sample/34589/
A major opportunity is emerging in rapid point-of-care diagnostics, where testing can be performed directly in veterinary clinics or farm environments instead of requiring samples to be sent to centralized laboratories. Advances in AI-based image interpretation, automated hematology, digital cytology and molecular testing are shortening turnaround times and expanding the range of conditions that can be evaluated during a veterinary visit. The MMR analysis identifies point-of-care tools and AI-enabled diagnostic systems among the important opportunities shaping future market development.
United States Veterinary Diagnostics Market Trends and Investment in 2025
The United States remained a central market for veterinary diagnostic innovation during 2025. IDEXX introduced IDEXX Cancer Dx, a blood-based diagnostic panel designed initially for early detection of canine lymphoma, expanding the role of diagnostics from disease confirmation toward earlier screening. The company also launched the Catalyst Cortisol Test in June 2025, allowing veterinarians to obtain quantitative cortisol measurements at the point of care for dogs being evaluated for Addison’s disease and Cushing’s syndrome.
Investment in laboratory infrastructure also increased. In May 2025, Zoetis opened its largest diagnostics reference laboratory in Louisville, Kentucky, expanding testing capacity and using the location’s logistics infrastructure to improve sample movement and turnaround times across the United States.
Federal disease-surveillance infrastructure further supports diagnostic demand. USDA’s National Animal Health Laboratory Network reported USD 43.16 million in FY2025 allocated funding, including support for veterinary diagnostic infrastructure, high-pathogenic avian influenza testing and emerging dairy-cattle disease events.
Market Segmentation: Leading Segments
By testing type, Immunoassays or Immunodiagnostics dominated the Veterinary Diagnostics Market in 2025. Their leadership is supported by widespread use in detecting infectious diseases, hormones and metabolic conditions. ELISA, lateral-flow testing and automated immunoassay systems offer relatively rapid, sensitive and cost-effective testing options for both laboratories and point-of-care environments.
By end use, the Laboratories segment held approximately 49% of the market in 2025, representing the largest share. Diagnostic laboratories remain essential for disease surveillance, confirmatory testing, research, quality assurance and national programs for monitoring transboundary animal diseases.
English
Français